CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MYLAN

VTRS
$10.38B
Large Cap
NASDAQPharmaceutical PreparationsPharmaceuticals🇺🇸North AmericaCANONSBURG32.0K employees

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.

Website

Drugs in Pipeline

201

Phase 3 Programs

148

Upcoming Catalysts

5

Next Catalyst

Aug 6, 2026

6w

Market Overview

Stock performance and key metrics

VTRS News
Catalyst Timeline

7 upcoming, 0 past

Drug Pipeline

Benefix

Phase 3

Hemophilia B

pramipexol

Phase 3

Idiopathic Restless Legs Syndrome

PF-08634404

Phase 3

Small Cell Lung Cancer (SCLC)

23-valent Pneumococcal Polysaccharide Vaccine (23vPS)

Phase 3

Pneumococcal Infections

Sumatriptan 25 mg

Phase 3

Migraine With or Without Aura

MYL- 1401O

Phase 3

Breast Cancer

SPM 907

Phase 3

Overactive Bladder

Bosutinib

Phase 3

Chronic Myeloid Leukemia

Fluconazole

Phase 3

Meningitis, Cryptococcal

Anidulafungin

Phase 3

Candidiasis

torcetrapib/atorvastatin

Phase 3

Hyperlipidemia

Inhaled Insulin

Phase 3

Diabetes Mellitus

ibuzatrelvir

Phase 3

COVID-19 SARS-CoV-2 Infection

Levonorgestrel/Ethinyl Estradiol

Phase 3

Premenstrual Syndrome

7-valent pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

13 valent pneumococcal conjugate vaccine

Phase 3

Influenza

Rimegepant

Phase 3

Migraine, With or Without Aura

Encorafenib

Phase 3

Melanoma

PF-04965842 100 mg

Phase 3

Dermatitis, Atopic

SU011248

Phase 3

Gastrointestinal Stromal Tumor

20-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Disease

Investigational medical product (IMP) administered in parent study

Phase 3

Osteoarthritis

PMI-150 (intranasal ketamine)

Phase 3

Pain, Postoperative

13-valent pneumococcal conjugate vaccine

Phase 3

HIV Infections

Dexmedetomidine

Phase 3

Anesthesia

valdecoxib

Phase 3

Pharyngitis

VLA15

Phase 3

Lyme Borreliosis

DVS SR

Phase 3

Major Depressive Disorder

MYL-1701P

Phase 3

Diabetic Macular Edema

CP-690,550

Phase 3

Rheumatoid Arthritis

pegaptanib sodium

Phase 3

Macular Edema

20vPnC

Phase 3

Pneumococcal Disease

tofacitinib

Phase 3

Ulcerative Colitis

Zavegepant

Phase 3

Migraine

ReFacto AF

Phase 3

Hemophilia A

Desvenlafaxine Succinate Sustained-Release (DVS SR)

Phase 3

Major Depressive Disorder

Varenicline

Phase 3

Smoking Cessation

Chemotherapy

Phase 3

Breast Neoplasms

Etanercept

Phase 3

Arthritis, Rheumatoid

Pantoprazole

Phase 3

Peptic Ulcer Hemorrhage

Dexmedetomidine hydrochloride

Phase 3

ICU Sedation

Bifeprunox

Phase 3

Depression Bipolar

Tigecycline

Phase 3

Bacterial Infections

linezolid

Phase 3

Infections, Nosocomial

erlotinib

Phase 3

Carcinoma, Non-Small Cell Lung

Tanezumab 5 mg

Phase 3

Low Back Pain

DVS-233 SR

Phase 3

Major Depressive Disorder

tanezumab

Phase 3

Arthritis

Paclitaxel

Phase 3

Non-Small Cell Lung Cancer

RSVpreF

Phase 3

RESPIRATORY SYNCYTIAL VIRUS (RSV)

PF-07220060

Phase 3

Breast Cancer

13-valent pneumococcal conjugate vaccine (13vPnC)

Phase 3

Invasive Pneumococcal Disease

Enzalutamide

Phase 3

Advanced, Androgen Receptor Positive Triple Negative Breast Cancer

7 valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Infections

13vPnC

Phase 3

Pneumococcal Disease

fesoterodine fumarate

Phase 3

Overactive Bladder

varenicline (CP-526,555)

Phase 3

Smoking Cessation

Palbociclib

Phase 3

Advanced Breast Cancer Female

ziprasidone versus olanzapine , risperidone or quetiapine

Phase 3

Schizophrenia

Amlodipine/atorvastatin single pill

Phase 3

Hypertension

MYL-1601D Product

Phase 3

Diabetes Mellitus, Type 1

venlafaxine ER 75 mg/day (fixed dose)

Phase 3

Major Depressive Disorder

Risperidone

Phase 3

Schizophrenia

LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION

Phase 3

Glaucoma, Primary Open Angle (POAG)

Revefenacin

Phase 3

Chronic Obstructive Pulmonary Disease, COPD

Econazole Nitrate Cream, 1%

Phase 3

Tinea Pedis

Eletriptan 20 mg

Phase 3

Migraine With or Without Aura

Eletriptan 80 mg

Phase 3

Migraine With or Without Aura

pramipexole

Phase 3

Restless Legs Syndrome

Diclofenac sodium gel 1%

Phase 3

Osteoarthritis, Knee

tolterodine extended release capsule

Phase 3

Urinary Incontinence

iv sildenafil

Phase 3

Pulmonary Hypertension, Familial Persistent, of the Newborn

olanzapine

Phase 3

Schizophrenia

Venlafaxine ER

Phase 3

Major Depressive Disorder

Venlafaxine XR

Phase 3

Anxiety

Xalacom

Phase 3

Glaucoma, Open Angle

Mylan's insulin glargine

Phase 3

Type 1 Diabetes

Lantus®

Phase 3

Type 2 Diabetes

MYL-1701P, a proposed biosimilar to Eylea

Phase 3

Diabetic Macular Edema

Pimecrolimus Cream, 1%

Phase 3

Atopic Dermatitis

Ziprasidone

Phase 3

Schizophrenia

Gabapentin

Phase 3

Transient Insomnia

Sildenafil citrate

Phase 3

Pulmonary Arterial Hypertension, Children

Transdermal system containing progestin

Phase 3

Female Contraception

MYL-1501D product using manufacture process V

Phase 3

Diabetes Mellitus, Type 1

Eletriptan HBr 40 mg

Phase 3

Migraine Without Aura

Eplerenone

Phase 3

Heart Failure

sildenafil citrate (UK-92,480)

Phase 3

Pulmonary Hypertension

Geodon (Ziprasidone)

Phase 3

Bipolar Disorder

pregabalin (Lyrica)

Phase 3

Diabetic Neuropathy, Painful

Xalatan

Phase 3

Glaucoma, Open-Angle

Diphenhydramine citrate

Phase 3

Healthy

Indomethacin

Phase 3

Arthritis, Gouty

Atorvastatin calcium 10 mg

Phase 3

Hypercholesterolemia

Ziprasidone Oral Capsule

Phase 3

Bipolar Mania

Pregabalin Dose Level 1

Phase 3

Partial Onset Seizures

Intramuscular ziprasidone mesylate

Phase 3

Schizophrenia

Nebivolol

Phase 3

Hypertension

Revefenacin 175 mcg in 3 ML Inhalation Solution

Phase 3

COPD

Timolol

Phase 3

Open Angle Glaucoma

Amlodipine

Phase 3

Hypertension

Amlodipine/Atorvastatin

Phase 3

Hypertension

Pregabalin Dose Level 2

Phase 3

Generalized Tonic Clonic Seizures

pregabalin

Phase 3

Generalized Anxiety Disorder

Clozapine

Phase 3

Schizophrenia

Estradiol Vaginal Cream, 0.01%

Phase 3

Atrophic Vaginitis

Eletriptan 40 mg

Phase 3

Migraine With or Without Aura

Nebivolol and Atenolol

Phase 3

Hypertension

TD-4208

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Amlodipine 2.5mg/Atorvastatin 5mg

Phase 3

Hypertension

latanoprost 0.005%

Phase 3

Ocular Hypertension

celecoxib and ibuprofen SR

Phase 3

Pain, Postoperative

Lamotrigine

Phase 3

Epilepsy, Partial

MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)

Phase 3

Asthma

Ziprasidone oral capsules

Phase 3

Bipolar Disorder

atorvastatin

Phase 3

Familial Hypercholesterolemia

apomorphine HCl injection

Phase 3

Parkinson Disease

PhXA41

Phase 3

Open Angle Glaucoma

Celecoxib

Phase 3

Low Back Pain

Tiotropium

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Pregabalin add-on therapy

Phase 3

Epilepsy, Partial Seizures

MR-100A-01

Phase 3

Contraception

MYL-1401A (Adalimumab)

Phase 3

Psoriasis

Nebivolol (NEB)

Phase 3

Hypertension

levetiracetam

Phase 3

Partial Seizures

sildenafil

Phase 3

Sexual Dysfunctions, Psychological

i. Fixed combination of latanoprost 0.005% and timolol 0.5%

Phase 3

Ocular Hypertension

MYL-1401H

Phase 3

Breast Neoplasms

latanoprost

Phase 3

Glaucoma

tramadol HCL

Phase 3

Low Back Pain

Epoetin Hospira

Phase 3

Chronic Renal Failure Requiring Hemodialysis

azithromycin SR (Zithromax; compound: CP-62,993)

Phase 3

Bronchitis, Chronic

Tafamidis

Phase 3

ATTR-PN

Voriconazole

Phase 3

Pharmacokinetics

Taliglucerase alfa

Phase 3

Gaucher Disease

Etrasimod

Phase 3

Ulcerative Colitis

naproxen

Phase 3

Osteoarthritis

7-valent pneumococcal conjugate vaccine (7vPnC)

Phase 3

Vaccines

Fesoterodine

Phase 3

Overactive Bladder

Bazedoxifene/Conjugated Estrogen

Phase 3

Vasomotor Symptoms Associated With Menopause

Formoterol

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Diclofenac SR

Phase 3

Ankylosing Spondylitis

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

Effexor XR

Phase 3

Depression

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Phase 3

Encephalitis, Tick-borne

Azithromycin

Phase 3

Pelvic Inflammatory Disease

cisplatin

Phase 3

Lung Cancer

Somatropin

Phase 3

Growth Hormone Therapy

PF-03654746

Phase 2

Attention Deficit Hyperactivity Disorder

PF-00489791

Phase 2

Hypertension

PF-06651600

Phase 2

Crohn's Disease

rhBMP-2/CPM

Phase 2

Fractures

tucatinib

Phase 2

HER2 Positive Breast Cancer

[S,S]-Reboxetine

Phase 2

Pain

MR-130A-01 contraceptive transdermal patch, containing norelgestromin (NGMN)

Phase 2

Contraception

Multivalent group B streptococcus vaccine

Phase 2

Group B Streptococcal Infections

Fx-1006A

Phase 2

Cardiomyopathy

PF-00610355

Phase 2

Pulmonary Disease, Chronic Obstructive

RSV vaccine

Phase 2

Respiratory Tract Infection

PF-06700841

Phase 2

Psoriasis

WNT974

Phase 2

Metastatic Colorectal Cancer

sertraline/[S,S]-reboxetine

Phase 2

Depressive Disorder, Major

AN2690

Phase 2

Onychomycosis

Alprazolam

Phase 2

Dental Anxiety

Irinotecan

Phase 2

Breast Neoplasms

TD-4208 700 μg

Phase 2

Chronic Obstructive Pulmonary Disease, COPD

MR-107A-01

Phase 2

Pain

binimetinib

Phase 2

Melanoma

CP-526,555 (varenicline)

Phase 2

Smoking Cessation

Sunitinib malate

Phase 2

Carcinoma, Renal Cell

ARRY-334543, EGFR/ErbB2 inhibitor; oral

Phase 2

Advanced Cancer

MR-130A-01 Transdermal patch

Phase 2

Contraception

MR-107A-02

Phase 2

Acute Pain

PF-3512676

Phase 2

Melanoma

latanoprost 75 ug

Phase 2

Primary Open Angle Glaucoma

Sunitinib

Phase 2

Stomach Neoplasms

Sildenafil 100 mg

Phase 2

Female Sexual Arousal Disorder

CP-547,632

Phase 2

Lung Neoplasms

PF-06650833

Phase 2

Rheumatoid Arthritis

PH-797804

Phase 2

Neuralgia, Postherpetic

Multivalent

Phase 2

Pneumococcal Infections

ERB-041

Phase 2

Dysmenorrhea

tofimilast

Phase 2

Pulmonary Disease, Chronic Obstructive

crisaborole ointment

Phase 2

Stasis Dermatitis

EXC 001

Phase 2

Scar Prevention

CP-751,871

Phase 2

Carcinoma, Non-Small-Cell Lung

PF-05089771

Phase 2

Inherited Erythromelalgia

Cysteamine

Phase 2

HIV Infections

EKB-569

Phase 2

Non-Small-Cell Lung Carcinoma

PF-06882961

Phase 2

Diabetes Mellitus, Type 2

Dacomitinib (PF-00299804)

Phase 2

Carcinoma, Non-small Cell

Permethrin Foam 4%

Phase 2

Scabies

leflunomide

Phase 2

Brain and Central Nervous System Tumors

Gemtuzumab Ozogamicin

Phase 2

Acute Myeloid Leukemia

AN2690 Solution, 5.0%

Phase 2

Onychomycosis

UK-369,003

Phase 2

Pulmonary Disease, Chronic Obstructive

Disitamab vedotin

Phase 2

Breast Cancer

Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)

Phase 2

Depressive Disorder, Major Depressive Disorder

PF-04965842 200 mg

Phase 2

Atopic Dermatitis

CP-866,087

Phase 2

Sexual Dysfunction, Physiological

Tick-borne encephalitis vaccine

Phase 2

Tick-borne Encephalitis

Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply